Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Outlook Therapeutics, Inc.Listing on record | Buy | n/a (No price was disclosed in the filing) | conv 69ClusterFirst in 12mo | SEC | |
Outlook Therapeutics, Inc.Listing on record | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC | |
Outlook Therapeutics, Inc.Listing on record | Buy | $3M | conv 26 | SEC | |
Outlook Therapeutics, Inc.Listing on record | Buy | $1M | conv 20First in 12mo | SEC |